Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes
- PMID: 34545407
- DOI: 10.1093/eurheartj/ehab677
Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes
Comment on
-
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.Eur Heart J. 2021 Dec 1;42(45):4638-4651. doi: 10.1093/eurheartj/ehab246. Eur Heart J. 2021. PMID: 34002203 Free PMC article.
-
Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.Eur Heart J. 2021 Dec 1;42(45):4697-4698. doi: 10.1093/eurheartj/ehab676. Eur Heart J. 2021. PMID: 34545390 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
